United Kingdom· GB-APID-3752711000001100
Isocarboxazid 10mg tablets
A isocarboxazid product containing isocarboxazid, registered in United Kingdom by Alliance Pharmaceuticals Ltd. The same ATC class is registered in 3 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Isocarboxazid is registered in 3 of 19 countries.
Countries holding a registration under ATC N06AF01 (isocarboxazid), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Isocarboxazid · ATC N06AF01
3 / 19 countries
- Denmark
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Isocarboxazid
- Manufacturer
- Alliance Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- N06AF01
- ATC class
- Isocarboxazid
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- October 2, 2026
Packs & prices · 2
- gtin5036631009155
- gtin5036631010700
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
190 interactions on record for isocarboxazid.
Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Isocarboxazid · interactions on record
190 records
- 45 severe
- 134 moderate
- 11 minor
Most severe, free to view
- IsomethepteneA03AX10severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Isocarboxazid in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Denmark · Marplan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/795deb97-18c0-4d00-824a-efc99c1fd8a3 GET /v1/drugs/795deb97-18c0-4d00-824a-efc99c1fd8a3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "3752711000001100",
"desc": "Isocarboxazid 10mg tablets (Alliance Pharmaceuticals Ltd)",
"form": "Oral tablet",
"vpid": "42273411000001101",
"source": "dmd",
"vtm_id": "776402009",
"strength": "10 mg",
"substance": "Isocarboxazid",
"ingredient": "Isocarboxazid",
"supplier_code": "3417301000001102"
}See everything about isocarboxazid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.